danazol has been researched along with stanozolol in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (39.29) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Agostoni, A; Cicardi, M | 1 |
| Agostoni, A; Agostoni, G; Bergamaschini, L; Cicardi, M; Cugno, M; Hack, E | 1 |
| Zhang, H | 1 |
| Branellec, A; Intrator, L; Lagrue, G; Laurent, J; Sobel, A | 1 |
| Brestel, EP; Thrush, LB | 1 |
| Späth, P; Wüthrich, B | 1 |
| Basomba, A; Campos, A; García Villalmanzo, I; Guerrero, M; Peláez, A; Prieto, L | 1 |
| Brickman, CM; Hosea, SW | 1 |
| Curd, JG; Pizzo, CJ; Prograis, LJ; Yelvington, M | 1 |
| Bütler, R; Späth, PJ; Wüthrich, B | 1 |
| Agostoni, A; Bergamaschini, L; Cicardi, M; Marasini, B; Martignoni, GC | 1 |
| Späth, P; Wüthrich, B; Zimmermann, HP | 1 |
| Agostoni, A; Bergamaschini, L; Cicardi, M; Coggi, G; Colombi, R; Tornaghi, G; Tucci, A; Viale, G | 1 |
| Agostoni, A; Bergamaschini, L; Cicardi, M; Tucci, A | 1 |
| Boada, LD; Cabrera, N; Chirino, R; del Rio, I; Díaz-Chico, BN; Fernández, L; Navarro, D | 1 |
| Agostoni, A; Bisiani, G; Cicardi, M; Cugno, M; Späth, P | 1 |
| Boada, LD; Chirino, R; Díaz-Chico, BN; Fernández, L; López, A; Luzardo, OP; Zumbado, M | 1 |
| Agostoni, A; Castelli, R; Cicardi, M; Zingale, LC | 1 |
| Roselli, CE | 1 |
| Glovsky, MM | 1 |
| Arland, M; Florschütz, A; Franke, A; Höffkes, HG; Jentsch-Ullrich, K; Kahl, C; Leuner, S | 1 |
| Díaz-Chico, BN; Fernández, L; Luzardo, OP; Machín, RP | 1 |
| Bazargan, N; Farhoudi, A; Mahmoudi, M; Pourpak, Z | 1 |
| Banerji, A; Sheffer, AL; Sloane, DE | 1 |
| Bork, K | 1 |
| Riedl, MA | 1 |
| Han, B; Li, HM; Long, ZB; Wang, T | 1 |
5 review(s) available for danazol and stanozolol
| Article | Year |
|---|---|
Hereditary angioedema.
Topics: Adult; Aminocaproic Acid; Angioedema; Child; Complement C1 Inactivator Proteins; Danazol; Female; Humans; Male; Methyltestosterone; Oxymetholone; Phenotype; Stanozolol | 1983 |
[Angioedema caused by C1 esterase inhibitor deficiency].
Topics: Anabolic Agents; Angioedema; Antifibrinolytic Agents; Complement C1 Inactivator Proteins; Danazol; Estrogen Antagonists; Humans; Immunosuppressive Agents; Plasmapheresis; Stanozolol | 1998 |
Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema.
Topics: Androgens; Angioedemas, Hereditary; Child; Clinical Trials as Topic; Danazol; Estrogen Antagonists; Female; Humans; Male; Oxymetholone; Stanozolol | 2008 |
Current management options for hereditary angioedema.
Topics: Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Danazol; Disease Management; Humans; Oxandrolone; Peptides; Plasma; Recombinant Proteins; Stanozolol | 2012 |
Critical appraisal of androgen use in hereditary angioedema: a systematic review.
Topics: Androgens; Angioedemas, Hereditary; Animals; Danazol; Drug Dosage Calculations; Female; Humans; Lipid Metabolism; Menstruation Disturbances; Obesity; Risk Assessment; Stanozolol; Time Factors; Virilism | 2015 |
1 trial(s) available for danazol and stanozolol
| Article | Year |
|---|---|
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Androgens; Angioedema; Blood Urea Nitrogen; Cholesterol; Creatine; Creatine Kinase; Danazol; Drug Therapy, Combination; Female; Humans; Hypertension; Hypothyroidism; Male; Menstruation Disturbances; Middle Aged; Myocardial Infarction; Potassium; Sodium; Stanozolol; Weight Gain | 1997 |
22 other study(ies) available for danazol and stanozolol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Autoimmune Diseases; Causality; Child; Complement C1 Inactivator Proteins; Danazol; Female; Follow-Up Studies; Genetic Diseases, Inborn; Hospitals, University; Humans; Italy; Male; Middle Aged; Phenotype; Stanozolol; Treatment Outcome | 1992 |
Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Antigens; Child; Child, Preschool; Complement C1 Inactivator Proteins; Complement C4; Danazol; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Stanozolol | 1991 |
[Long-term therapy of hereditary angioedema].
Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Danazol; Female; Humans; Male; Middle Aged; Pregnadienes; Stanozolol | 1990 |
[Prolonged preventive treatment of hereditary angioneurotic edema with anabolic androgenic steroids].
Topics: Adolescent; Adult; Aged; Anabolic Agents; Angioedema; Danazol; Female; Humans; Male; Methandrostenolone; Middle Aged; Stanozolol; Time Factors | 1986 |
The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol.
Topics: Adult; Chronic Disease; Danazol; Drug Synergism; Female; Glucocorticoids; Humans; Middle Aged; Stanozolol; Urticaria | 1988 |
[Hereditary angioedema and androgen therapy].
Topics: Angioedema; Complement C1 Inactivator Proteins; Danazol; Heterozygote; Humans; Stanozolol; Testosterone Congeners | 1985 |
[Familial angioedema (II). Treatment].
Topics: Aminocaproic Acid; Angioedema; Cinnarizine; Complement C1 Inactivator Proteins; Danazol; Histamine H1 Antagonists; Humans; Stanozolol; Tranexamic Acid | 1984 |
Immunodiffusion assay of C1 inhibitor function in serum: prospective analysis in angioedema-urticaria.
Topics: Angioedema; Complement C1 Inactivator Proteins; Danazol; Humans; Immunodiffusion; Prospective Studies; Stanozolol; Urticaria; Vasculitis | 1983 |
C1 inhibitor functional activities in hereditary angioedema plasma of patients under therapy with attenuated androgens.
Topics: Angioedema; Complement C4; Danazol; Female; Humans; Immunodiffusion; Male; Nephelometry and Turbidimetry; Pregnadienes; Stanozolol | 1984 |
Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema.
Topics: Adult; Androstadienes; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Danazol; Female; Humans; Long-Term Care; Male; Mesterolone; Middle Aged; Nandrolone; Pregnadienes; Stanozolol | 1980 |
[Hereditary angioedema. A clinical and immunologic contribution based on our 8 clinical cases under long-term treatment with androgens].
Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Danazol; Female; Humans; Male; Middle Aged; Pedigree; Stanozolol | 1983 |
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives.
Topics: Adult; Angioedema; Danazol; Drug Administration Schedule; Female; Humans; Liver; Male; Middle Aged; Mitochondrial Swelling; Pregnadienes; Stanozolol | 1983 |
Effect of treatment with 17 alpha-alkylated androgens on C4 conversion products in hereditary angioedema studied by crossed immunoelectrophoresis.
Topics: Adult; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Danazol; Electrophoresis, Agar Gel; Female; Humans; Immunoelectrophoresis, Two-Dimensional; Male; Pregnadienes; Stanozolol | 1982 |
Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes.
Topics: Animals; Binding Sites; Binding, Competitive; Cycloheximide; Danazol; Dexamethasone; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Stanozolol; Time Factors | 1994 |
Autoimmune C1 inhibitor deficiency: report of eight patients.
Topics: Aged; Angioedema; Antibodies, Catalytic; Autoantibodies; Autoimmune Diseases; Complement C1 Inactivator Proteins; Complement C1q; Complement C4; Danazol; Female; Humans; Male; Middle Aged; Stanozolol | 1993 |
[3H]dexamethasone binding activity in liver microsomes is modulated differently by 17 alpha-alkylated androgens and testosterone in vivo.
Topics: Anabolic Agents; Animals; Cycloheximide; Danazol; Dexamethasone; Drug Interactions; Estrogen Antagonists; Liver Function Tests; Male; Microsomes, Liver; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Stanozolol; Testosterone; Tritium | 1995 |
The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area.
Topics: Anabolic Agents; Androgens; Animals; Antineoplastic Agents, Hormonal; Aromatase; Danazol; Dihydrotestosterone; Enzyme Activation; Estrogen Antagonists; Injections, Subcutaneous; Male; Methandrostenolone; Nandrolone; Orchiectomy; Organ Size; Preoptic Area; Prostate; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Stanozolol; Testosterone | 1998 |
C1 esterase inhibitor transfusions in patients with hereditary angioedema.
Topics: Angioedema; Blood Transfusion; Complement C1 Inactivator Proteins; Danazol; Humans; Stanozolol | 1998 |
Photoaffinity labeling identification of a specific binding protein for the anabolic steroids stanozolol and danazol: an oligomeric protein regulated by age, pituitary hormones, and ethinyl estradiol.
Topics: Aging; Anabolic Agents; Animals; Carrier Proteins; Centrifugation, Density Gradient; Chromatography, Gel; Danazol; Electrophoresis, Polyacrylamide Gel; Estrogen Antagonists; Ethinyl Estradiol; Hypophysectomy; Liver; Male; Membrane Proteins; Microsomes, Liver; Photoaffinity Labels; Pituitary Hormones; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stanozolol; Subcellular Fractions | 2000 |
Two related cases of primary complement deficiency.
Topics: Adult; Anti-Bacterial Agents; Complement C3; Danazol; Dyspnea; Edema; Female; Genetic Diseases, Inborn; Glomerulonephritis; Humans; Male; Meningitis, Pneumococcal; Pedigree; Stanozolol | 2003 |
[Efficacy of stanozolol and danazol in the treatment of non-severe aplastic anemia and their effects on CD4(+)CD25(+)Foxp3(+) regulatory T cells].
Topics: Anemia, Aplastic; CD4-Positive T-Lymphocytes; Danazol; Forkhead Transcription Factors; Humans; Interleukin-2 Receptor alpha Subunit; Stanozolol; T-Lymphocytes, Regulatory; Transcription Factors | 2022 |